Division of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, China.
Ann Hepatol. 2012 Jul-Aug;11(4):471-7.
Living donor liver transplantation (LDLT) for patients with high model for end-stage liver disease (MELD) scores is controversial due to its poor outcome. However, there is little information regarding which factor would negatively impact the outcome of patients with high MELD scores. The aim of this study was to identify factors associated with the in-hospital mortality of patients with high MELD scores after LDLT.
All patients with an MELD scores ≥ 20 who received LDLT from 2005 to 2011 were recruited for the present study. Pre- and intra-operative variables were retrospectively and statistically analyzed.
A total of 61 patients were included in the current study. The overall 3-month survival rate was 82% for patients with high MELD scores. Preoperative renal dysfunction, hyponatremia, starting albumin level < 2.8 g/dL, preoperative renal replacement for severe renal failure, anhepatic period > 100 minutes and intraoperative red blood cell (RBC) transfusion ≥ 10 units were identified as potential risk factors by univariate analysis. However, only hyponatremia, preoperative dialysis and massive RBC transfusion were independent risk factors in a multivariate analysis. The 3-month survival rates of patients with two or more independent risk factors and patients with none or one risk factor were 91 and 25%, respectively. A significant difference was observed (P < 0.001).
Hyponatremia, preoperative dialysis and massive RBC transfusion were related to poor outcome for sicker patients. Patients with two or more of the above-mentioned risk factors and high MELD scores may exhibit extremely poor short-term survival.
由于预后较差,对于 MELD 评分较高的患者,活体肝移植(LDLT)存在争议。然而,关于哪些因素会对 MELD 评分较高患者的预后产生负面影响的信息很少。本研究的目的是确定与 LDLT 后 MELD 评分较高患者住院死亡率相关的因素。
本研究纳入了 2005 年至 2011 年接受 LDLT 的所有 MELD 评分≥20 的患者。回顾性和统计学分析了术前和术中变量。
共有 61 例患者纳入本研究。MELD 评分较高患者的 3 个月总体生存率为 82%。单因素分析显示,术前肾功能不全、低钠血症、白蛋白起始水平<2.8 g/dL、术前因严重肾衰竭行肾脏替代治疗、无肝期>100 分钟和术中红细胞(RBC)输注≥10 单位是潜在的危险因素。然而,多因素分析仅显示低钠血症、术前透析和大量 RBC 输注是独立的危险因素。有两个或更多独立危险因素的患者和无或只有一个危险因素的患者的 3 个月生存率分别为 91%和 25%,差异有统计学意义(P<0.001)。
低钠血症、术前透析和大量 RBC 输注与病情较重患者的不良预后相关。MELD 评分较高且具有上述两个或更多危险因素的患者可能会表现出极差的短期生存率。